You are here: Industry Insights > Clinical Trial

News List

Taysha Gene Therapies Announces Positive Safety Data from UT Southwestern-Sponsored Clinical Trial for the Treatment of CLN7 Batten Disease at 18th Annual WORLDSymposium FirstWordPharma
February 10, 2022
Taysha Gene Therapies, Inc. (Nasdaq: TSHA), a patient-centric, pivotal-stage gene therapy company focused on developing and commercializing AAV-based gene therapies for the treatment of monogenic diseases...
HanAll Biopharma Reports Full-Year 2021 Results and Provides Business Update prnasia
January 21, 2022
HanAll Biopharma (KRX: 009420.KS) announced today that it achieved 101.6 billion won in sales in 2021, a 15% increase from the previous year. It had 10.1 billion won in operating profit, a 70% increase year-on-year...
Suvoda Exceeds 2021 Targets; Poised for Continued Growth Supporting Complex Clinical Trials in 2022 prnasia
January 21, 2022
Suvoda, LLC, a global clinical trial technology company that specializes in highly complex studies, such as oncology, central nervous system (CNS) and rare disease...
Catalent Launches New Xpress Pharmaceutics Service contractpharma
January 18, 2022
Expedites development of oral drugs for adaptive phase 1 clinical trials.
Green Valley Obtains IND Approval from U.S. FDA for Sodium Oligomannate's Global Phase II Clinical Trial in Treating Parkinson's Disease prnasia
January 17, 2022
Green Valley (Shanghai) Pharmaceuticals Co., Ltd. received the letter from the US Food and Drug Administration (FDA) on the Investigational New Drug (IND) application for the global multi-center phase-II clinical trial of Oligomannate...
Ascletis Announces First Patient Dosed in the Phase II Clinical Trial of FASN Inhibitor ASC40 for Treatment of Moderate to Severe Acne prnasia
January 14, 2022
Ascletis Pharma Inc. (HKEX: 1672) today announces the dosing of the first patient in the Phase II clinical trial of ASC40 for moderate to severe acne. ASC40 is an oral, selective inhibitor of fatty acid synthase (FASN)...
Revive Therapeutics Provides Update on Phase 3 Clinical Trial for Bucillamine in COVID-19 FirstWordPharma
December 30, 2021
Revive Therapeutics Ltd. ("Revive" or the "Company") (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT: 31R), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders...
Luye Pharma Releases Top-Line Results from a Phase II Clinical Trial of Its New Antidepressant Ansofaxine Hydrochloride Extended-Release Tablets prnasia
December 24, 2021
Luye Pharma Group today released the encouraging top-line results from a Phase II clinical trial of its new antidepressant, Ansofaxine Hydrochloride Extended-Release Tablets (LY03005)...
UK regulator publishes guidance on use of real-world data to support clinical trials EuropeanPharmaceuticalReview
December 20, 2021
Two new guidance documents, the first in a series to published by the MHRA, outline considerations when planning a randomised clinical trial using real-world data.
Digital transformation will improve clinical trial process, say experts EuropeanPharmaceuticalReview
December 20, 2021
In a new survey, 35 percent of healthcare professionals believe that digital transformation would improve pre-clinical and clinical trials.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 28 29 Next page